Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In one landmark trial, adults without diabetes who took the highest weekly dose lost an average of 20.9 percent of their body weight over 72 weeks, compared with 3.1 percent on placebo, and more than half reached at least a 20 percent reduction (SURMOUNT-1 trial, New England Journal of Medicine, 2022)
Gamba et al, 2013
Once you reach effective dose, weight loss continues at 1-2 pounds weekly as long as calorie deficit persists
You will be shown how to choose and rotate injection sites, such as the abdomen, thigh, or upper arm, to ensure proper absorption and minimize discomfort
Tirzepatide (Subcutaneous Route) Drug Information
US$ 25.60
US$ 22.10
US$ 23.67
US$ 23.75
